Nuclear Medicine

The Department of Nuclear Medicine was established in 1975. After several decades of development, it has become a comprehensive department integrating medical care, teaching, and scientific research. It is one of the first national-level standardized residency training bases, a unit serving as deputy chief editor of nationally planned textbooks, and a unit for the training of master’s postgraduate students; it has successively become the chairing unit of the Nuclear Medicine Branch of the Shandong Medical Association, the Nuclear Medicine Professional Committee of the Shandong Hospital Association, and the Nuclear Medicine and Molecular Imaging Physicians Branch of the Shandong Medical Doctors Association.

The department has advanced equipment such as PET/CT, a cyclotron, SPECT/CT, and a technetium gas generator, among others, and can routinely perform tumor imaging and organ functional imaging, including thyroid and parathyroid imaging, myocardial ischemia and viability imaging, Alzheimer’s disease Aβ imaging, and others.

The department has established a standardized radionuclide therapy ward and carries out 131I therapy for differentiated thyroid cancer, 177Lu-PSMA therapy for prostate cancer, 90Y-microsphere therapy for liver cancer, and others; it is also qualified to use radionuclides such as 225Ac and 223Ra.